Investigating kidney health in children and adolescents
Official title: The Central Biochemistry Laboratory for the Chronic Kidney Disease in Children Cohort (CKiD)
Funded at University of Minnesota · NIH-10929494 · Data updated 2026-11-12
This study is looking at how chronic kidney disease affects kids and teens by testing their blood and kidney function to help doctors better understand and care for young patients with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project start | September 15, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $316,218 |
| NIH project number | 5U24DK137522-02 |
| Project ID | NIH-10929494 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children and adolescents aged 14 to 17 years who are experiencing chronic kidney disease.
✕Less likely to help
Patients outside the age range of 0 to 21 years or those without chronic kidney disease may not benefit from this research.
What this research studies
This research focuses on understanding chronic kidney disease (CKD) in children and adolescents by analyzing blood samples and measuring kidney function using advanced laboratory techniques. The study aims to improve the accuracy of kidney function estimates specifically for young patients, which is crucial for their health management. By examining the relationship between CKD and various developmental aspects, including neurocognitive and social development, the research seeks to provide insights that can enhance patient care. Participants will undergo routine diagnostic testing and specialized biomarker assessments to contribute to this important research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate kidney function assessments in children, improving their treatment and health outcomes.
How similar studies have gone: Previous research has shown success in using advanced biomarker testing to improve kidney function assessments in pediatric populations, indicating a promising approach.
Where this research is happening
-
University of Minnesota
Minneapolis, United States Active
Researchers
- Principal investigator: Seegmiller, Jesse C — University of Minnesota
- Study coordinator: Seegmiller, Jesse C
Related research
Other NIH-funded projects on the same topics.
-
Personalized CKD-MBD care using systems biology and AI
A patient-facing program aims to tailor mineral-balance therapy for people with chronic kidney disease by using a computer model and smart decision rules to predict who will respond best to treatments.
-
Mitigating DKA in people with type 1 diabetes and kidney disease using SGLT1/2 inhibitors
This project tests a new way to prevent dangerous diabetic ketoacidosis in people with type 1 diabetes and chronic kidney disease who are using SGLT inhibitors, by tracking ketones in real time and combining glucose-keton data for safer therapy.
-
Chronic Kidney Disease in Children: following young people as they grow up with CKD
A long-term study in kids with chronic kidney disease tracks kidney function and heart health as they transition into adulthood.
-
Chronic Kidney Disease in Children follow-up study
A long-term study that follows kids with kidney disease as they grow into young adults, collecting health data from home and official records.
-
Malaria-related kidney injury and its link to chronic kidney disease in children
This grant looks at why some children who have malaria develop kidney injury and later chronic kidney disease, focusing on how severe malaria affects the kidneys over time.
-
Boosting self-care and physical activity for older adults with chronic kidney disease
This program helps older adults with chronic kidney disease build the skills, confidence, and motivation to be more physically active.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.